Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer’s dementia

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia

Multi-ancestry transcriptome-wide association studies of cognitive function, white matter hyperintensity, and Alzheimer’s disease

Bayesian Genome-wide TWAS method to leverage both cis- and trans- eQTL information through summary statistics

SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning

Proteome-wide association studies using summary pQTL data of three tissues identified 30 risk genes of Alzheimer's disease dementia

Integrate GWAS, Eqtl, and Mqtl Data to Identify Alzheimer’s Disease-Related Genes

SR-TWAS: Leveraging Multiple Reference Panels to Improve TWAS Power by Ensemble Machine Learning

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Opportunities and Challenges for Transcriptome-Wide Association Studies

Integrative Analysis of Summary Data from GWAS and Eqtl Studies Implicates Genes Differentially Expressed in Alzheimer's Disease.

kTWAS: Integrating kernel-machine with transcriptome-wide association studies improves statistical power and reveals novel genes

Single-nucleus transcriptome-wide association study of human brain disorders

Brain-Specific Gene Expression and Quantitative Traits Association Analysis for Mild Cognitive Impairment

Voxelwise genome-wide association study (vGWAS)

Identification of 5 Potential Predictive Biomarkers for Alzheimer’s Disease by Integrating the Unified Test for Molecular Signatures and Weighted Gene Coexpression Network Analysis

Identification of Alzheimer's Disease-Related Genes Based on Data Integration Method

A Novel Method Based on Linear Regression Model for Identify the Sensitivity of Quantitative Trait in ADNI Cohort

CWAS-Plus: Estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data

Enhancing Disease Risk Gene Discovery by Integrating Transcription Factor-Linked Trans-located Variants into Transcriptome-Wide Association Analyses